Artelo Biosciences, Inc. (ARTL) Misses Q3 EPS by 18c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.83), $0.18 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• Donaldson (DCI) Tops Q4 EPS by 2c ; Offers Guidance
• Deutsche Bank sees stabilization in European MedTech and Life Sciences